PELLERINO, Alessia
PELLERINO, Alessia
A Novel Prognostic Marker for Primary CNS Lymphoma: Lactate Dehydrogenase-to-Lymphocyte Ratio Improves Stratification of Patients Within the Low and Intermediate MSKCC Risk Groups
2021-01-01 Gao Y.; Wei L.; Kim S.J.; Wang L.; He Y.; Zheng Y.; Bertero L.; Pellerino A.; Cassoni P.; Tamagnone L.; Theresa P.K.; Deutsch A.; Zhan H.; Lai J.; Wang Y.; You H.
A novel prognostic model based on pretreatment serum albumin and ECOG PS for primary CNS lymphoma: an international, multi-center study
2023-01-01 Wei, Li; Gao, Yuting; Prochazka, Katharina Theresa; Liu, Rongqiu; Wang, Liang; Liu, Boyang; He, Yingzhi; Bertero, Luca; Pellerino, Alessia; Cassoni, Paola; Tamagnone, Luca; Deutsch, Alexander J; Zhan, Huien; Lai, Jing; Kim, Seok Jin; You, Hua
An approach to the timing of altered localization of TDP-43 in ALS motor neurons during disease progression
2009-01-01 Giordana MT; Grifoni S; Piccinini M; Pellerino A; De Marco G ; Buccinnà B ; Lupino E ; Naldi A; Magistrello M; Rinaudo MT
Antiangiogenic Therapy for Malignant Brain Tumors: Does It Still Matter?
2023-01-01 Pellerino, Alessia; Bruno, Francesco; Soffietti, Riccardo; Rudà, Roberta
Antiangiogenic therapy of brain tumors: The role of bevacizumab
2014-01-01 Trevisan, Elisa; Bertero, Luca; Bosa, Chiara; Magistrello, Michela; Pellerino, Alessia; Rudà, Roberta; Soffietti, Riccardo
Biomarker for Frontotemporal Lobar Degeneration (FTLD) with TDP-43 Pathology: the Circulating Lymphocytes
2012-01-01 Pellerino A; Lomartire A; Naldi A; Buccinna B; Maffeo E; Ramondetti C; Lupino E; Rinaudo MT; Piccinini M; Rainero I; De Marco G; Giordana MT
Blood–Brain Barrier in Brain Tumors: Biology and Clinical Relevance
2021-01-01 Mo, Francesca; Pellerino, Alessia; Soffietti, Riccardo; Rudà, Roberta
Brain metastasis from HER2-positive breast cancer: an evolving landscape
2022-01-01 Soffietti, Riccardo; Pellerino, Alessia
Choosing appropriate chemotherapy for diffusely infiltrating WHO grade II gliomas in adults.
2020-01-01 Pellerino A, Bertero L, RudA R, Soffietti R
Clinical Significance of Molecular Alterations and Systemic Therapy for Meningiomas: Where Do We Stand?
2022-01-01 Alessia Pellerino, Francesco Bruno, Rosa Palmiero, Edoardo Pronello, Luca Bertero, Riccardo Soffietti, Roberta Rudà
Complete response of spinal metastases from non-small cell lung cancer with ALK inhibitors
2019-01-01 Pellerino A.; Buffoni L.; Ruda R.; Soffietti R.
Correction to: Efficacy of initial temozolomide for high‑risk low grade gliomas in a phase II AINO (Italian Association for Neuro‑Oncology) study: a post‑hoc analysis within molecular subgroups of WHO 2016
2019-01-01 Rudà, Roberta; Pellerino, Alessia; Pace, Andrea; Carapella, Carmine Maria; Dealis, Cristina; Caroli, Manuela; Faedi, Marina; Bello, Lorenzo; Migliore, Enrica; Marchese, Giulia; Bertero, Luca; Cassoni, Paola; Soffietti, Riccardo
Current clinical management of elderly patients with glioma
2020-01-01 Pellerino, Alessia; Bruno, Francesco; Internò, Valeria; Ruda', Roberta; Soffietti, Riccardo
Dementia and cognitive impairment in amyotrophic lateral sclerosis: a review.
2011-01-01 Giordana MT; Ferrero P; Grifoni S; Pellerino A; Naldi A; Montuschi A.
Depatuxizumab mafodotin (Depatux-M) plus temozolomide (TMZ) in recurrent glioblastoma patients: Real-world experience from a multicenter study of Italian Association of Neuro-Oncology (AINO)
2020-01-01 Mario Caccese, Marta Padovan, Marica Eoli, Alessia Pellerino, Simona Rizzato, Claudia Caserta, Matteo Simonelli, Maria Michiara, Vittorina Zagonel, Roberta Ruda, Giuseppe Lombardi
Depatuxizumab mafodotin (Depatux-m) plus temozolomide in recurrent glioblastoma patients: Real-world experience from a multicenter study of italian association of neuro-oncology (aino)
2021-01-01 Padovan M.; Eoli M.; Pellerino A.; Rizzato S.; Caserta C.; Simonelli M.; Michiara M.; Caccese M.; Anghileri E.; Cerretti G.; Ruda R.; Zagonel V.; Lombardi G.
Diagnosis and Treatment of Peripheral and Cranial Nerve Tumors with Expert Recommendations: An EUropean Network for RAre CANcers (EURACAN) Initiative
2023-01-01 Pellerino, Alessia; Verdijk, Robert M.; Nichelli, Lucia; Andratschke, Nicolaus H.; Idbaih, Ahmed; Goldbrunner, Roland
Does valproic acid affect tumor growth and improve survival in glioblastomas?
2016-01-01 Rudà, Roberta; Pellerino, Alessia; Soffietti, Riccardo
Efficacy of initial temozolomide for high-risk low grade gliomas in a phase II AINO (Italian Association for Neuro-Oncology) study: a post-hoc analysis within molecular subgroups of WHO 2016
2019-01-01 Ruda R.; Pellerino A.; Pace A.; Carapella C.M.; Dealis C.; Caroli M.; Faedi M.; Bello L.; Migliore E.; Marchese G.; Bertero L.; Cassoni P.; Soffietti R.
Elderly Gliobastoma Patients: The Impact of Surgery and Adjuvant Treatments on Survival. A Single Institution Experience
2022-01-01 Bruno, Francesco; Pellerino, Alessia; Pronello, Edoardo; Palmiero, Rosa; Bertero, Luca; Mantovani, Cristina; Bianconi, Andrea; Melcarne, Antonio; Garbossa, Diego; Ruda, Roberta
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A Novel Prognostic Marker for Primary CNS Lymphoma: Lactate Dehydrogenase-to-Lymphocyte Ratio Improves Stratification of Patients Within the Low and Intermediate MSKCC Risk Groups | 2021 | Gao Y.; Wei L.; Kim S.J.; Wang L.; He Y.; Zheng Y.; Bertero L.; Pellerino A.; Cassoni P.; Tamagnone L.; Theresa P.K.; Deutsch A.; Zhan H.; Lai J.; Wang Y.; You H. | |
| A novel prognostic model based on pretreatment serum albumin and ECOG PS for primary CNS lymphoma: an international, multi-center study | 2023 | Wei, Li; Gao, Yuting; Prochazka, Katharina Theresa; Liu, Rongqiu; Wang, Liang; Liu, Boyang; He, Yingzhi; Bertero, Luca; Pellerino, Alessia; Cassoni, Paola; Tamagnone, Luca; Deutsch, Alexander J; Zhan, Huien; Lai, Jing; Kim, Seok Jin; You, Hua | |
| An approach to the timing of altered localization of TDP-43 in ALS motor neurons during disease progression | 2009 | Giordana MT; Grifoni S; Piccinini M; Pellerino A; De Marco G ; Buccinnà B ; Lupino E ; Naldi A; Magistrello M; Rinaudo MT | |
| Antiangiogenic Therapy for Malignant Brain Tumors: Does It Still Matter? | 2023 | Pellerino, Alessia; Bruno, Francesco; Soffietti, Riccardo; Rudà, Roberta | |
| Antiangiogenic therapy of brain tumors: The role of bevacizumab | 2014 | Trevisan, Elisa; Bertero, Luca; Bosa, Chiara; Magistrello, Michela; Pellerino, Alessia; Rudà, Roberta; Soffietti, Riccardo | |
| Biomarker for Frontotemporal Lobar Degeneration (FTLD) with TDP-43 Pathology: the Circulating Lymphocytes | 2012 | Pellerino A; Lomartire A; Naldi A; Buccinna B; Maffeo E; Ramondetti C; Lupino E; Rinaudo MT; Piccinini M; Rainero I; De Marco G; Giordana MT | |
| Blood–Brain Barrier in Brain Tumors: Biology and Clinical Relevance | 2021 | Mo, Francesca; Pellerino, Alessia; Soffietti, Riccardo; Rudà, Roberta | |
| Brain metastasis from HER2-positive breast cancer: an evolving landscape | 2022 | Soffietti, Riccardo; Pellerino, Alessia | |
| Choosing appropriate chemotherapy for diffusely infiltrating WHO grade II gliomas in adults. | 2020 | Pellerino A, Bertero L, RudA R, Soffietti R | |
| Clinical Significance of Molecular Alterations and Systemic Therapy for Meningiomas: Where Do We Stand? | 2022 | Alessia Pellerino, Francesco Bruno, Rosa Palmiero, Edoardo Pronello, Luca Bertero, Riccardo Soffietti, Roberta Rudà | |
| Complete response of spinal metastases from non-small cell lung cancer with ALK inhibitors | 2019 | Pellerino A.; Buffoni L.; Ruda R.; Soffietti R. | |
| Correction to: Efficacy of initial temozolomide for high‑risk low grade gliomas in a phase II AINO (Italian Association for Neuro‑Oncology) study: a post‑hoc analysis within molecular subgroups of WHO 2016 | 2019 | Rudà, Roberta; Pellerino, Alessia; Pace, Andrea; Carapella, Carmine Maria; Dealis, Cristina; Caroli, Manuela; Faedi, Marina; Bello, Lorenzo; Migliore, Enrica; Marchese, Giulia; Bertero, Luca; Cassoni, Paola; Soffietti, Riccardo | |
| Current clinical management of elderly patients with glioma | 2020 | Pellerino, Alessia; Bruno, Francesco; Internò, Valeria; Ruda', Roberta; Soffietti, Riccardo | |
| Dementia and cognitive impairment in amyotrophic lateral sclerosis: a review. | 2011 | Giordana MT; Ferrero P; Grifoni S; Pellerino A; Naldi A; Montuschi A. | |
| Depatuxizumab mafodotin (Depatux-M) plus temozolomide (TMZ) in recurrent glioblastoma patients: Real-world experience from a multicenter study of Italian Association of Neuro-Oncology (AINO) | 2020 | Mario Caccese, Marta Padovan, Marica Eoli, Alessia Pellerino, Simona Rizzato, Claudia Caserta, Matteo Simonelli, Maria Michiara, Vittorina Zagonel, Roberta Ruda, Giuseppe Lombardi | |
| Depatuxizumab mafodotin (Depatux-m) plus temozolomide in recurrent glioblastoma patients: Real-world experience from a multicenter study of italian association of neuro-oncology (aino) | 2021 | Padovan M.; Eoli M.; Pellerino A.; Rizzato S.; Caserta C.; Simonelli M.; Michiara M.; Caccese M.; Anghileri E.; Cerretti G.; Ruda R.; Zagonel V.; Lombardi G. | |
| Diagnosis and Treatment of Peripheral and Cranial Nerve Tumors with Expert Recommendations: An EUropean Network for RAre CANcers (EURACAN) Initiative | 2023 | Pellerino, Alessia; Verdijk, Robert M.; Nichelli, Lucia; Andratschke, Nicolaus H.; Idbaih, Ahmed; Goldbrunner, Roland | |
| Does valproic acid affect tumor growth and improve survival in glioblastomas? | 2016 | Rudà, Roberta; Pellerino, Alessia; Soffietti, Riccardo | |
| Efficacy of initial temozolomide for high-risk low grade gliomas in a phase II AINO (Italian Association for Neuro-Oncology) study: a post-hoc analysis within molecular subgroups of WHO 2016 | 2019 | Ruda R.; Pellerino A.; Pace A.; Carapella C.M.; Dealis C.; Caroli M.; Faedi M.; Bello L.; Migliore E.; Marchese G.; Bertero L.; Cassoni P.; Soffietti R. | |
| Elderly Gliobastoma Patients: The Impact of Surgery and Adjuvant Treatments on Survival. A Single Institution Experience | 2022 | Bruno, Francesco; Pellerino, Alessia; Pronello, Edoardo; Palmiero, Rosa; Bertero, Luca; Mantovani, Cristina; Bianconi, Andrea; Melcarne, Antonio; Garbossa, Diego; Ruda, Roberta |